youtube_live
Inntekt Q3 2026
Se detaljenechevron_right
GH:NASDAQ
Guardant Health Inc
153,43 USD
arrow_downward
−8,99%(−15,15) 1 D
137,35 USD
arrow_downward
−10,48% (−16,08)bedtimeEtter stengetid
Stengt: 5. nov., 16:00:02 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for GH …
Åpne
165,00 USD
Høy
165,10 USD
Lav
151,92 USD
Markedsverdi
20,59 mrd.
Snittvolum
1,81 mill.
Volum
4,07 mill.
52 u høy
191,01 USD
52 u lav
74,55 USD
EPS
−3,50 USD
Beta
1,67
Utestående aksjer
134,20 mill.
Antall ansatte
2k
Åpne
165,00 USD
Høy
165,10 USD
Lav
151,92 USD
Markedsverdi
20,59 mrd.
Snittvolum
1,81 mill.
Volum
4,07 mill.
52 u høy
191,01 USD
52 u lav
74,55 USD
EPS
−3,50 USD
Beta
1,67
Utestående aksjer
134,20 mill.
Antall ansatte
2k
Nyhetssaker
Fra nettkilder og nyhetspartnere
marketscreener.com
·
for 30 minutter siden
(GH) Guardant Health Now Expects Full Year 2026 Revenue Range $1.36B - $1.37B, vs. FactSet Est of $1.36B
Investing.com UK
·
for 48 minutter siden
Guardant Health earnings beat by $0.46, revenue topped estimates
FinancialContent
·
for 1 time siden
Guardant Health’s (NASDAQ:GH) Q3 2026 sales beat estimates but stock drops 10.2%
Investor's Business Daily
·
for 1 time siden
It Was Already A Gory Day For Blood-Testing Stocks — Then, Natera And Guardant Reported
Profil
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
Om Guardant Health Inc
Administrerende direktørHelmy Eltoukhy | AmirAli Talasaz
Ansatte2,5k
Grunnlagt2012
HovedkontorPalo Alto, California, USA
SektorHealth Care
Industry-
Nettstedguardanthealth.com